Impact of Glycemic Control on Skeletal Outcomes in Adults With Type 1 Diabetes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

163 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-04

Study Completion Date

2025-08-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background : Type 1 diabetes (T1D) is associated with an increased risk of fractures. The mechanisms accounting for this bone fragility are not yet fully understood. As T1D is often diagnosed in childhood or early adulthood, the lower bone mineral density (BMD) and deteriorated bone microarchitecture observed in T1D may reflect changes in the bone that occurred before or at the time of peak bone mass achievement. There is a lack of high-quality prospective studies to determine whether adults with T1D continue to lose BMD or deteriorate bone quality compared with controls. Moreover, while chronic hyperglycemia is a risk factor for fracture in T1D, it is unknown if better glycemic control affects bone outcomes.

This prospective multicenter cohort study aims: (1) To compare the changes in the following outcomes over 4 years in adults with T1D and controls without diabetes of similar age, sex and body-mass index distribution: BMD by dual-energy X-ray absorptiometry (DXA) at the femoral neck, hip, spine, and radius, trabecular bone score (TBS) by DXA, and serum biochemical markers of bone turnover (BTMs); (2) To evaluate whether long-term glycemic control or the presence of a microvascular complication are independent predictors of the changes in BMD and TBS in people with T1D.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of Vertebral Fractures in Patients With Type 1 Diabetes

NCT04064437

Diabetes Mellitus, Type 1 Bone Fracture Bone Health

COMPLETED

Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk

NCT05701254

Type 1 Diabetes Osteopenia Bone Loss +1 more

RECRUITING

Type 1 Diabetes Mellitus Effect on Bone Mineral Density

NCT01633684

Diabetes Mellitus Osteoporosis

COMPLETED

Bone Health and Microbiome in Persons With Type 1 Diabetes

NCT04784975

Type1diabetes

COMPLETED

Bone Health in Type 1 Diabetes

NCT00651196

Type 1 Diabetes Osteoporosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 1 Bone Health Bone Loss Bone Diseases, Metabolic Hyperglycaemia Due to Type 1 Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.